SeaStar Medical Holding Corp

SeaStar Medical Holding Corporation (Nasdaq: LMAO) is a medical device company focused on selective cytopheretic device technology targeting acute inflammatory conditions, including acute kidney injury in critically ill patients. The company completed its SPAC merger with Pono Capital Two Corp in 2022, with Pono Capital Two LLC serving as sponsor. On May 7, 2026, SeaStar Medical filed an amended registration statement on Form S-1/A with the SEC, accession number 0001213900-26-053076, continuing its post-combination reporting obligations in the medical devices and healthcare technology sector. Sign up on SpacDesk for full filings, analytics, and deal-level data on SeaStar Medical and every active SPAC.